MIT develops a new vaccine offering protection against SARS-CoV-2 variants and related sarbecoviruses, addressing future pandemic threats.

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

President Donald Trump announced a $500billion investment for private companies to develop artificial intelligence tools to ...

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” could have ...

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

Not long after the Illinois Department of Health announced the state’s overall respiratory illness cases had reached the ...

Public health experts say there could be massive implications after President Trump signed an executive order withdrawing the U.S. from the World Health Organization.

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...